Key result
Intracoronary heptanol increases inducible sustained VT rates to ~36% vs control in post-MI dogs.
Why the study?
Abnormal cellular coupling contributes to slow, dissociated conduction supporting ventricular tachycardia after myocardial infarction, and agents modulating coupling may affect arrhythmia susceptibility.
Does intracoronary heptanol modulate conduction and susceptibility to inducible ventricular tachycardia in a canine model of healed myocardial infarction?
Does intracoronary heptanol modulate conduction and susceptibility to inducible ventricular tachycardia in a canine model of healed myocardial infarction?
In a canine model of healed myocardial infarction, heptanol demonstrated a bimodal effect on ventricular tachycardia susceptibility, highlighting the complex role of cellular coupling modulation in arrhythmogenesis.
Answers are grounded in this paper and cite their sources.
Bimodal VT effects in canine MI model caution against clinical translation; leaves open selective gap junction modulation as antiarrhythmic strategy.
Effect of Heptanol in Healed Infarction. Introduction: Abnormal cellular coupling is a major constituent of the slow, dissociated conduction that supports ventricular tachycardia (VT) following myocardial infarction. Agents that modulate cellular coupling may exert either proarrhythmic or antiarrhythmic effects. Methods and Results: The effects of modulating cellular coupling on conduction and susceptibility to inducible VT were studied in 11 dogs with healed left anterior descending (LAD) infarction. The LAD circulation was isolated and supplied with arterial blood via a constant‐flow bypass system. Localized intracoronary infusion of heptanol, an agent with relatively specific effects on intracellular coupling, was performed using this bypass system. Heptanol produced dose‐dependent changes in cardiac conduction, assessed by delayed local activation times in sinus rhythm (0.5 mM: 11.9%± 11.0% change, P = 0.005; 1.0 mM: 45.8%± 25.5% change, P = 0.0004) and slowed conduction velocity both transverse and longitudinal to fiber orientation. Sustained VT was not induced in any of the control animals. During infusion of 0.5 mM heptanol, uniform sustained VT was inducible in 4 of 11 animals (P = 0.027). During infusion of 1.0 mM heptanol, sustained VT was induced in only 1 of 9 animals. Concltisions: In the canine model of healed myocardial infarction, heptanol had a bimodal effect on susceptibility to inducible VT. Low‐dose heptanol facilitated the induction of sustained VT, and high‐dose heptanol had an antiarrhythmic effect. This suggests that agents that modulate coupling may significantly modify susceptibility to VT following myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Callans et al. (1996) studied Healed myocardial infarction (n=11). Heptanol vs. Control (no heptanol) was evaluated on Inducible sustained ventricular tachycardia (VT) (p=0.027). Intracoronary infusion of 0.5 mM heptanol facilitated the induction of sustained ventricular tachycardia compared to control in dogs with healed myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: